Associate II Manufacturing, Cell Therapy at Bristol-Myers Squibb

Leiden, South Holland, Netherlands

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years), Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

General understanding of Good Manufacturing Practices (GMPs)
Goal-oriented and flexible
Ability to work effectively and efficiently on a team
Demonstrates safety, quality, and GMP compliance at all times
Innovative and intellectually curious
Ability to work within a controlled cleanroom environment and execute aseptic processing procedures (as assigned)

Responsibilities

Learn and execute Cell Therapy Manufacturing operations
Perform patient process unit operations and support operations described in standard operating procedures and batch records
Execute transactions and processes in all electronic systems
Prioritize safety of self and others
Report safety events within 24 hours
Escalate any/all issues that may impact safety of self and/or others
Complete documentation required by governing controlled documents and batch records
Perform all tasks in a manner consistent with safety policies, SOPs, quality systems, and GMP requirements
Complete training assignments to ensure necessary technical skills and knowledge
Train for proficiency in process systems and some supporting business systems
Execute daily unit operations schedule, including people, product, and material flow across multiple shifts
Maintain manufacturing environmental conditions (Non-Viable Particulates and Viable microbial levels per controlled area classification specifications) by performing area disinfection regimen as required to meet global Health Authority requirements
Continue to refine and improve manufacturing process technique to improve individual operational times
Ensure training completion

Skills

Cell Therapy Manufacturing

GMP

Bioprocessing

Commercial Manufacturing

Aseptic Processing

Production Line Optimization

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free